Communicable disease threats report, 22-28 November 2020, week 48
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 22-28 November 2020 and includes updates on COVID-19, cholera, dengue, seasonal influenza and West Nile fever.
HIV/AIDS surveillance in Europe 2020 (2019 data)
This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been summarizing data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
Prevention of hepatitis B and C in the EU/EEA and the UK
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
Updated projections of COVID-19 in the EU/EEA and the UK
In May 2020, ECDC produced a set of short-term forecasts of the expected number of COVID-19 cases, deaths and hospitalised cases (subdivided into general hospital wards and intensive care units). Updated forecasts were published in September 2020. In this report we present slightly longer-term projections for each country, up until 25 December 2020.
Avian influenza overview – update on 19 November 2020, EU/EEA and the UK
Since 16 October 2020, outbreaks of highly pathogenic avian influenza (HPAI) viruses have been reported in several EU/EEA countries – Belgium, Denmark, France, Germany, Ireland, the Netherlands, and Sweden as well as in the United Kingdom.
Communicable disease threats report, 15-21 November 2020, week 47
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 15-21 November 2020 and includes updates on COVID-19, Ebola virus disease, dengue, influenza A(H1N2), Legionnaires' disease, seasonal influenza, West Nile fever and TBE.
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK
This ECDC document is intended to facilitate further discussions between Member States with the aim of reaching agreement on the criteria to be used for the selection of rapid antigen tests, as well as scenarios and settings during which it is appropriate to use rapid antigen tests. This document is also intended to support clinical validations of rapid antigen tests.
Rapid Risk Assessment: Increase in fatal cases of COVID-19 among long-term care facility residents in the EU/EEA and the UK
This risk assessment details the latest epidemiological data in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) with a focus on older age groups and national reports of outbreaks among residents of LTCFs. All EU/EEA countries and the UK have experienced outbreaks among LTCF residents since August 2020.
Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report for 2019
This report is based on data reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) for the period 2015 to 2019, retrieved from The European Surveillance System (TESSy) and ECDC’s decentralised data storage for antimicrobial resistance and healthcare-associated infections (ARHAI) on 10 September 2020.
Antimicrobial consumption - Annual Epidemiological Report for 2019
In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.